Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 443

1.

The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.

Minond D, Lauer-Fields JL, Cudic M, Overall CM, Pei D, Brew K, Visse R, Nagase H, Fields GB.

J Biol Chem. 2006 Dec 15;281(50):38302-13. Epub 2006 Oct 25.

PMID:
17065155
[PubMed - indexed for MEDLINE]
Free Article
2.

Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.

Minond D, Lauer-Fields JL, Nagase H, Fields GB.

Biochemistry. 2004 Sep 14;43(36):11474-81.

PMID:
15350133
[PubMed - indexed for MEDLINE]
3.

Use of Edman degradation sequence analysis and matrix-assisted laser desorption/ionization mass spectrometry in designing substrates for matrix metalloproteinases.

Lauer-Fields JL, Nagase H, Fields GB.

J Chromatogr A. 2000 Aug 18;890(1):117-25.

PMID:
10976799
[PubMed - indexed for MEDLINE]
4.

Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.

Lauer-Fields JL, Broder T, Sritharan T, Chung L, Nagase H, Fields GB.

Biochemistry. 2001 May 15;40(19):5795-803.

PMID:
11341845
[PubMed - indexed for MEDLINE]
6.

Matrix metalloproteinases and collagen catabolism.

Lauer-Fields JL, Juska D, Fields GB.

Biopolymers. 2002;66(1):19-32. Review.

PMID:
12228918
[PubMed - indexed for MEDLINE]
7.

Analysis of matrix metalloproteinase triple-helical peptidase activity with substrates incorporating fluorogenic L- or D-amino acids.

Lauer-Fields JL, Kele P, Sui G, Nagase H, Leblanc RM, Fields GB.

Anal Biochem. 2003 Oct 1;321(1):105-15.

PMID:
12963061
[PubMed - indexed for MEDLINE]
8.

Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.

Lauer-Fields JL, Sritharan T, Stack MS, Nagase H, Fields GB.

J Biol Chem. 2003 May 16;278(20):18140-5. Epub 2003 Mar 17.

PMID:
12642591
[PubMed - indexed for MEDLINE]
Free Article
10.

Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases.

Ottl J, Gabriel D, Murphy G, Knäuper V, Tominaga Y, Nagase H, Kröger M, Tschesche H, Bode W, Moroder L.

Chem Biol. 2000 Feb;7(2):119-32.

PMID:
10662694
[PubMed - indexed for MEDLINE]
Free Article
11.

Triple-helical peptide analysis of collagenolytic protease activity.

Lauer-Fields JL, Fields GB.

Biol Chem. 2002 Jul-Aug;383(7-8):1095-105. Review.

PMID:
12437092
[PubMed - indexed for MEDLINE]
12.

Substrate conformation modulates aggrecanase (ADAMTS-4) affinity and sequence specificity. Suggestion of a common topological specificity for functionally diverse proteases.

Lauer-Fields JL, Minond D, Sritharan T, Kashiwagi M, Nagase H, Fields GB.

J Biol Chem. 2007 Jan 5;282(1):142-50. Epub 2006 Nov 9.

PMID:
17095512
[PubMed - indexed for MEDLINE]
Free Article
13.

Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases.

Lauer-Fields JL, Tuzinski KA, Shimokawa Ki, Nagase H, Fields GB.

J Biol Chem. 2000 May 5;275(18):13282-90.

PMID:
10788434
[PubMed - indexed for MEDLINE]
Free Article
14.

Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.

Lauer-Fields J, Brew K, Whitehead JK, Li S, Hammer RP, Fields GB.

J Am Chem Soc. 2007 Aug 29;129(34):10408-17. Epub 2007 Aug 2.

PMID:
17672455
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Differentiation of secreted and membrane-type matrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences.

Minond D, Lauer-Fields JL, Cudic M, Overall CM, Pei D, Brew K, Moss ML, Fields GB.

Biochemistry. 2007 Mar 27;46(12):3724-33. Epub 2007 Mar 6.

PMID:
17338550
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Matrix metalloproteinase-1 takes advantage of the induced fit mechanism to cleave the triple-helical type I collagen molecule.

O'Farrell TJ, Guo R, Hasegawa H, Pourmotabbed T.

Biochemistry. 2006 Dec 26;45(51):15411-8.

PMID:
17176063
[PubMed - indexed for MEDLINE]
17.
18.

The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition.

Brandstetter H, Grams F, Glitz D, Lang A, Huber R, Bode W, Krell HW, Engh RA.

J Biol Chem. 2001 May 18;276(20):17405-12. Epub 2001 Jan 22.

PMID:
11278347
[PubMed - indexed for MEDLINE]
Free Article
19.

Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity.

Chung L, Shimokawa K, Dinakarpandian D, Grams F, Fields GB, Nagase H.

J Biol Chem. 2000 Sep 22;275(38):29610-7.

PMID:
10871619
[PubMed - indexed for MEDLINE]
Free Article
20.

Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.

Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF, Hambor JE.

J Clin Invest. 1996 Feb 1;97(3):761-8.

PMID:
8609233
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk